产品详情 |
Edit |   |
Product Name | BioSim™ Ramucirumab (Cyramza®)(Human) ELISA Kit |
Description | Ramucirumab is a human monoclonal antibody (IgG1) against vascular endothelial growth factor receptor 2 (VEGFR2), a type II trans-membrane tyrosine kinase receptor expressed on endothelial cells. By binding to VEGFR2, Ramucirumab prevents binding of its ligands (VEGF-A, VEGF-C, and VEGF-D), thereby preventing VEGF-stimulated receptor phosphorylation and downstream ligand-induced proliferation, permeability, and migration of human endothelial cells. BioSim™ Vedolizumab ELISA kit is a Solid phase enzyme-linked immunosorbent assay (ELISA) based on the sandwich principle. Standards and samples (serum or plasma) are incubated in the microtitre plate coated with the reactant for Ramucirumab (Cyramza®). After incubation, the wells are wa |
Size | 96 assays |
Concentration | n/a |
Applications | Sensitivity: 20 ng/ml,Detection Range: 20 - 600 ng/ml,Assay Precision: Intra-Assay: CV < 15%; Inter-Assay: CV < 15% (CV (%) = SD/mean X 100),Cross Reactivity: Except for Ramucirumab, there is no cross reaction with other therapeutic antibodies and native serum immunoglobins.,This ELISA kit is used for in vitro quantitative determination of Ramucirumab,Recovery rate: 85 - 115% with normal human serum samples with known concentrations |
Other Names | Cyramza elisa kit,Ramucirumab elisa kit |
Gene, Accession, CAS # | n/a |
Catalog # | E4698-100 |
Price | |
Order / More Info | BioSim™ Ramucirumab (Cyramza®)(Human) ELISA Kit from BIOVISION, INC. |
Product Specific References | n/a |
产品资料 |
|
|